Allergan Healthcare India, Bangalore has launched Juvéderm VOLUX in India under its business unit of Allergan Aesthetics. Allergan Aesthetics has obtained all the necessary approvals from the Central Drugs Standards Control Organization (CDSCO) office before launching this product in India.

Juvéderm VOLUX is a combination of Hyaluronic acid 25 mg + Lidocaine hydrochloride 3 mg and is an injectable implant intended to restore and create a volume of the face.

"The launch of Juvéderm VOLUX in India further strengthens our commitment to provide state-of-the-art options in the medical aesthetics market in India,” said Rahul Choudhary, GM, Allergan Aesthetics in India. “There is an increasing need for medical aesthetics globally and in India due to patients’ desire to empower their confidence. Allergan Aesthetics is strongly committed to the patients who are treated with our products. As part of our continuing medical education via the programmes offered by Allergan Medical Institute (AMI), healthcare professionals can be trained on the use of this new treatment," he added.